TY  - JOUR 
AU  - Carpintero Fernández, Paula
AU  - Borghesan, Michela
AU  - Eleftheriadou, Olga
AU  - Pan Castillo, Belén
AU  - Fafian Labora, Juan
AU  - Mitchell, Tom P
AU  - García Yuste, Alejandro
AU  - Ogrunc, Muge
AU  - Nightingale, Thomas D.
AU  - Mayán Santos, María Dolores
AU  - O'Loghlen, Ana
PY  - 2022
UR  - http://hdl.handle.net/20.500.11940/17064
AB  - During this last decade, the development of prosenescence therapies has become an attractive strategy as cellular senescence acts as a barrier against tumour progression. In this context, CDK4/6 inhibitors induce senescence and reduce tumour growth in...
LA  - eng
KW  - Breast Neoplasms
KW  - Cell Line, Tumor
KW  - Factor IX
TI  - Genome wide CRISPR/Cas9 screen identifies the coagulation factor IX (F9) as a regulator of senescence
DO  - 10.1038/s41419-022-04569-3.
T2  - Cell Death and Disease
M2  - 163
KW  - INIBIC
KW  - CHUAC
VL  - 13
ER  -